Inclusion Criteria:~1. Signed and dated written informed consent obtained from the subject and study companion
in accordance with applicable regulations~2. Male or female, aged 55 to 80 years, inclusive~3. For female
subjects: not being of child-bearing potential. This is defined as either permanently sterilised (via
hysterectomy, bilateral salpingectomy, or bilateral oophorectomy) or postmenopausal (defined as no menses for
12 months without an alternative medical cause)~4. Body mass index (BMI) between 18.5 and 30.0 kg/m2,
inclusive, (weight in kilograms and height in meters will be combined to report BMI in kg/m2)~5. Diagnosed with
MCI due to AD or mild dementia due to AD, according to the NIA-AA criteria11~6. MMSE score of 22 to 30 points
on a scale, inclusive, the highest score achievable is 30~7. Repeatable battery for the assessment of
neuropsychological status - delayed memory index (RBANS-DMI) score ≤85 units on a scale~8. CDR global score of
0.5 or 1 with a memory score ≥0.5 units on a scale~9. Confirmation of AD diagnosis, by~ * CSF biomarker profile
reflecting AD, according to NIA-AA11, or~ * existing positive amyloid positron emission tomography (PET)
evidence~10. Fluency in local language and evidence of adequate intellectual functioning in the opinion of the
investigator~11. Having a reliable informant or caregiver who is willing and able to act as the study companion
throughout the duration of the subject's participation. The subject and the study companion must have frequent
interaction (defined as a minimum of 6 hours/week on average) according to subject's report~
